It's time to think seriously about bispecifics as 'drug-like' molecules. About progressing your formats over preclinical hurdles and into the clinic. Efficacy and product differentiation remain the biggest challenges when advancing your research but there is a solution.
The World Bispecific Antibody Summit is an outstanding opportunity for you to learn lessons from the most successful drug developers in the field. For just a few days out of the office, you'll save months and potentially years of development heartache. You'll leave armed with dozens of new ideas that you can start using right away. And crucially, you'll find new, innovative and cost effective ways of overcoming troublesome preclinical and clinical development challenges.
Hear case studies from the leading pharma and biotech developers and understand the latest engineering approaches that are powering bispecific drugs into the clinic. Get answers from world-leading experts on crucial development questions on target selection, structure/function relationships, developability, biophysical characterization, pharmacokinetics, manufacturability, formulation. And of course - clinical development.
This year we'll be addressing every major multispecific format and highlighting what it's going to take to get them into human testing. Detailed case studies with fresh data will be presented covering every area of bispecific development. Learn how you can:
If you would like to find out more about this meeting you can:
"Impressive and excellent overview of different bispecific technologies" Covagen
“One of the most important events in the bispecific area” Abbott
“An excellent summit to hear about technology updates and current issues within the field of bispecific antibodies” Dyax
“Provides an excellent overview of the field of bispecifics and brings the people of the field together” Roche